Ars Live: The rise of GLP-1 drugs: Insights and Unknowns
Dr. Daniel Ducker traces the four-decade evolution of GLP-1 drugs from laboratory discovery to blockbuster therapies, revealing how these medications deliver cardiovascular and neurological benefits independent of weight loss while previewing innovations in multi-agonist formulations and oral delivery systems.